Cancer Survivor Paul Mann Speaking at FLCCC's Healthcare Revolution Conference (2024)

Watch full discussion here:
https://covid19criticalcare.com/courses/conference-2024/lessons/cancer-practical-solutions/

Repurposed drugs have played a vital role in treating COVID, long COVID, and long vax. Now, they are leaving their mark on a new medical battlefield: cancer. On a panel discussion, 'Cancer: Practical Solutions', in Phoenix, Arizona (February, 2024), Dr. Paul Mann - a prostate cancer patient who was told he had no hope of survival - shared his incredible story, in which he continues to recover through the use of the repurposed drug, ivermectin. The panel included an expert lineup: Dr. Kathleen Ruddy, Dr. Nathan Goodyear, and FLCCC's own Dr. Paul Marik. Their collaborative efforts are pioneering new directions in medical science, aiming to revolutionize cancer treatment. This is a remarkable story of hope, innovation, and the collective push towards patient empowerment and the future of cancer research.

Learn more about the FLCCC Observational Cancer Study here:
https://covid19criticalcare.com/cancer-study/

Watch all lectures, panels, and Q&As from the conference here:
https://covid19criticalcare.com/courses/conference-2024/

The FLCCC Alliance is a healthcare nonprofit on a mission to restore trust, integrity, and the doctor-patient relationship. Get involved by clicking below:

• Donate: https://geni.us/Donate-Today
• Follow: https://geni.us/Follow-FLCCC
• Protocols: https://geni.us/Treatment
• Webinar: https://geni.us/FLCCC-Webinar
• Shop: https://geni.us/Shop-FLCCC
• Medical Disclaimer: https://geni.us/Disclaimer